Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

BVT 2733

Inquiry
Cat. No.: OB0425LY-249
Synonyms: 376640-41-4; BVT-2733; 3-Chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide; BVT2733; Piperazine, 1-((2-(((3-chloro-2-methylphenyl)sulfonyl)amino)-4-thiazolyl)acetyl)-4-methyl-; Benzenesulfonamide, 3-chloro-2-methyl-N-(4-(2-(4-methyl-1-piperazinyl)-2-oxoethyl)-2-thiazolyl)-; 3-Chloro-2-methyl-N-[4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1,3-thiazol-2-yl]benzenesulfonamide
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 376640-41-4
Compound CID: 6918651
BVT 2733

Specification

Description: BVT 2733 is a selective non-steroidal 11β-hydroxydehydrogenase 1 (11β-HSD1) inhibitor.
Formula Weight: 428.96
Applications: BVT 2733 can be used to study metabolic syndrome, hyperglycemia and insulin resistance associated with type 2 diabetes, and to investigate its potential to improve glucose-lipid metabolism and cardiovascular health.
Storage: Storage at -20°C.
Formula: C17H21ClN4O3S2
Appearance: Solid
Purity: 99.72%, determined by LC-MS.
Solubility: DMSO
Pathway: Metabolic enzyme/Protease
Identity: Confirmed by LC-MS.
Target: 11β-HSD

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.